Edge Wealth Management LLC Ocugen, Inc. Transaction History

Edge Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$5.52 - $15.68 $165 - $470	-30 Closed	0 $0
Q1 2021 Apr 09, 2021	BUY	$1.66 - $15.81 $49 - $474	30 New	30 $1,000
Q1 2020 Apr 20, 2020	SELL	$0.26 - $0.73 $260 - $730	-1,000 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$0.27 - $2.19 $261 - $2,117	967 Added 2930.3%	1,000 $1,000
Q3 2019 Oct 21, 2019	BUY	$2.85 - $16.26 $94 - $536	33 New	33 $1,000

125

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $204M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.